PrimeRFP SCOUT · Federal Contract Recompete Brief

75F40122C00181Calibrating RWE studies in oncology against — Brigham & Womens Hospital Inc

Brigham & Womens Hospital Inc holds $20.7M across 79 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 5 related awards in the incumbent pipeline. The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Jan 29, 2027 PoP end — agencies typically plan 12–18 months ahead.

Fda Office Of Acq Grant Svcs

Awarding office

Brigham & Womens Hospital Inc

Recipient

Jan 29, 2027

PoP end

$3.7M

Obligated

$4.7M

Potential

541714

NAICS

AN11

PSC

NONE

Set-aside

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Brigham & Womens Hospital Inc — $90

Contract facts

NONE

Contract number75F40122C00181

AgencyFda Office Of Acq Grant Svcs

Awarding officeFda Office Of Acq Grant Svcs

Awarding agencyDepartment of Health and Human Services (HHS)

Funding agencyDepartment of Health and Human Services (HHS)

IncumbentBrigham & Womens Hospital Inc

CAGE0W3J1

UEIQN6MS4VN7BD1

NAICS541714

No full NAICS 541714 intel page yet. Browse NAICS intelligence

PSCAN11

Place of performanceSILVER SPRING MD

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition

PoP startSep 21, 2022

PoP end (current)Jan 29, 2027

Obligated$3.7M

Current value$4.7M

Potential value$4.7M

CALIBRATING RWE STUDIES IN ONCOLOGY AGAINST RANDOMIZED TRIALS is a federal NONE award for Fda Office Of Acq Grant Svcs held by Brigham & Womens Hospital Inc. Estimated value $4.7M ($3.7M obligated). Current period of performance ends Jan 29, 2027. Last award drew 1 bidder. Place of performance: SILVER SPRING MD.

CALIBRATING RWE STUDIES IN ONCOLOGY AGAINST RANDOMIZED TRIALS

Recompete timing

Public

● Expiring in 161 days

Current PoP ends Jan 29, 2027 (161 days remaining). Agencies typically plan 12–18 months ahead — at 5.3 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Brigham & Womens Hospital Inc — $20.7M obligated across 79 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).

% of firm-wide obligated ($20.7M) · all agencies

Department of Veterans Affairs (VA)$13.0M · 63%Department of Health and Human Services (HHS)$6.9M · 33%National Aeronautics and Space Administration (NASA)$1.5M · 7%Department of Justice (DOJ)$14K · 0%

Open full company profile →

Related awards

Same incumbent

36C24E25N0248

GGENOMIC MEDICINE RESEARCH

$229K

Sep 10, 2026

36C24E25N0234

BIOINFORMATICS RESEARCH SUPPORT

$559K

Sep 13, 2026

36C24E25N0231

BIOINFORMATICS RESEARCH SUPPORT - DIV OF AGING

$542K

Sep 13, 2026

36C24E25N0235

BIOINFORMATICS RESEARCH SUPPORT

$399K

Sep 13, 2026

36C24E25N0233

BIOINFORMATICS RESEARCH SUPPORT

$112K

Sep 13, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 75F40122C00181?

75F40122C00181 (Calibrating RWE studies in oncology against) is a Fda Office Of Acq Grant Svcs award with a potential value of $4.7M, currently held by Brigham & Womens Hospital Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75F40122C00181?

Fda Office Of Acq Grant Svcs awarded 75F40122C00181 to Brigham & Womens Hospital Inc (potential $4.7M).

Who is the incumbent on 75F40122C00181?

Brigham & Womens Hospital Inc is the incumbent with $20.7M across 79 related awards in SCOUT’s public footprint. The current period of performance ends Jan 29, 2027.

When does Brigham & Womens Hospital Inc’s 75F40122C00181 come up for recompete?

SCOUT tracks a period-of-performance end of Jan 29, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 26, 2026 · refreshed monthlyLatest procurement action Dec 27, 2024